October 22, 2020
UC San Diego researchers use experimental artificial intelligence system called DrugCell to predict the best approach to treating cancer. Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
March 7, 2013
What can green algae do for science if they weren’t, well, green? That’s the question biologists at UC San Diego sought to answer when they engineered a green alga used commonly in laboratories, Chlamydomonas reinhardtii, into a rainbow of different colors by producing six different colored fluorescent proteins in the…
May 21, 2013
…Training Program will pursue an innovative global health and development research project, titled “Outsmarting Malaria: Developing next generation anti-malarials that prevent the evolution of drug resistance.”
January 18, 2022
Countering a rising antibiotic resistance crisis, doctors now prescribe combinations of antibiotics. Yet many risks are involved with such multi-drug combinations. Scientists have developed a way to help doctors evaluate outcomes for different drug pairs and boost the odds of successful treatment.
May 3, 2016
Chemists at UC San Diego have developed a new tool that allows scientists for the first time to see, at the scale of five billionths of a meter, “nanoscale” mixing processes occurring in liquids.
February 1, 2024
UC San Diego scientists are working to flip the script on drug addiction with a $1.3 million grant from the W.M. Keck Foundation. Their new approach, called negative feedback chemogenetics, works by leveraging the body’s biochemical feedback processes to disrupt pathways associated with addiction.
March 19, 2012
Chemists at the University of California, San Diego have produced the first high resolution structure of a molecule that when attached to the genetic material of the hepatitis C virus prevents it from reproducing. Hepatitis C is a chronic infectious disease that affects some 170 million people worldwide and causes…
August 20, 2024
Researchers from UC San Diego are working on a new treatment for Alzheimer’s that targets tau - a type of protein in the brain that helps cells retain their stability and structure.
December 17, 2020
New simulations done on supercomputers may help researchers understand how these inhibitors react and potentially help to develop a new generation of drugs to target viruses with high death rates including SARS-CoV2, the virus that causes COVID-19.
October 8, 2015
…Ph.D. A Pediatric Cancer Drug Three Decades in the Making By the age of 4, Matthew Haemsch had undergone 16 rounds of chemotherapy and a surgery to remove a cancerous tumor on his adrenal gland. Yet, his small body remained riddled with a rare pediatric cancer. With no other treatment…
